DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Vasopressin ( DrugBank:
Vasopressin
)
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
210
単心室症
2
210. 単心室症
臨床試験数
:
51
/
薬物数
:
53
- (
DrugBank
:
22
) /
標的遺伝子数
:
32
-
標的パスウェイ数
:
67
10
50
100
ALL
diseases per page:
Showing 1 to 2 of 2 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT03088345
(
ClinicalTrials.gov
)
March 6, 2017
28/2/2017
Early Use of
Vasopressin
in Post-Fontan Management
Use of Arginine
Vasopressin
in Early Postoperative Management After Fontan Palliation
Circulatory Perfusion Disorder;Congenital Heart Disease;Single-ventricle
Drug:
Vasopressin
, Arginine;Drug: Placebo
Medical College of Wisconsin
NULL
Completed
N/A
18 Years
All
20
Phase 2/Phase 3
United States
2
NCT02975999
(
ClinicalTrials.gov
)
December 2016
22/9/2016
Use of
Vasopressin
Following the Fontan Operation
Use of
Vasopressin
Following the Fontan Operation: Both Pilot and Multicenter Studies
Pleural Effusion;Single-ventricle
Drug:
Vasopressin
;Drug: Normal Saline
Advocate Health Care
NULL
Withdrawn
18 Months
7 Years
All
0
Phase 2/Phase 3
United States